• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Cloning for presenilin cleaving enzyme

Research Project

Project/Area Number 11670943
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Psychiatric science
Research InstitutionOsaka University

Principal Investigator

KUDO Takashi  Graduate School of Medicine, Osaka University Lecturer, 医学系研究科, 講師 (10273632)

Co-Investigator(Kenkyū-buntansha) TANAKA Toshihisa  Graduate School of Medicine, Osaka University Assistant Professor, 医学系研究科, 助手 (10294068)
NAKAMURA Yu  Graduate School of Medicine, Osaka University Assistant Professor, 医学系研究科, 助手 (70291440)
TAKEDA Masatoshi  Graduate School of Medicine, Osaka University Professor, 医学系研究科, 教授 (00179649)
IMAIZUMI Kazunori  Medicen School, Osaka Univ., 医学系研究科, 講師
Project Period (FY) 1999 – 2000
Project Status Completed (Fiscal Year 2000)
Budget Amount *help
¥3,900,000 (Direct Cost: ¥3,900,000)
Fiscal Year 2000: ¥900,000 (Direct Cost: ¥900,000)
Fiscal Year 1999: ¥3,000,000 (Direct Cost: ¥3,000,000)
KeywordsAlzheimer disease / presenilin / endoplasmin reticulum / GRP 78 / アミロイド前駆体蛋白 / プレセニリン、 / 小胞体、 / 分子シャペロン
Research Abstract

Missenes mutations in the human presenilin-1 (PS1) gene, which is found on chromosome 14, cause early-onset familial Alzheimer's disease (FAD). FAD-linked PS1 variants alter proteolytic processing of the amyloid precursor protein and cause an increase in vulnerability to apoptosis induced by various cell stresses. However, the mechanisms responsible for these phenomena are not clear. Here we report that mutations in PS1 affect the unfolded-protein response (UPR), which responds to the increased amount of unfolded proteins that accumulate in the endoplasmic reticulum (ER) under conditions that cause ER stress. PS1 mutations also lead to decreased expression of GRP78/Bip, a molecular chaperone, present in the ER, that can enable protein folding. Interestingly, GRP78 levels me reduced in the brain of Alzheimer's disease patients. The downregulation of UPR signalling by PS1 mutations is caused by disturbed function of IRE1, which is the proximal sensor of conditions in the ER lumen. Overexpression of GRP78 in neuroblastoma cells bearing PS1 mutants almost completely restores resistance to ER stress to the level of cells expressing wild-type PS1. These results show that mutations in PS1 may increase vulnerability to ER stress by altering the UPR signalling pathway.

Report

(3 results)
  • 2000 Annual Research Report   Final Research Report Summary
  • 1999 Annual Research Report
  • Research Products

    (23 results)

All Other

All Publications (23 results)

  • [Publications] H.Tanimukai et al: "Regional distribution of presenilin-1 messenger RNA in the embryonic rat brain : comparison with β-amyloid precursor protein messenger RNA localization"Neuroscience. 90(1). 27-39 (1999)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Hitoshi Tanimukai et al: "Presenilin-2 mutation and polymorphism in Japanese Alzheimer disease patients"Clinica Chimica Acta. 283. 57-61 (1999)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Yuka Nakano et al: "Accumulation of murine amyloid β42 in a gene-dosage-dependent manner in PS1 'knock-in' mice"Eur.J.Neurosci.. 11. 2577-2581 (1999)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Katayama T et al: "Presenilin-1 mutations downregulate the signalling pathway of the unfolded-protein response."Nat Cell Biolog. 8. 479-485 (1999)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Takashi Kudo et al: "Are cerebrovascular factors involved in Alzheimer's disease?"Neurobio.Aging. 21. 215-224 (2000)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Naoya Sato et al: "Increased production of β-amyloid and vulnerability to endoplasmic reticulum stress by an aberrant spliced form of presenilin 2"J.Biol.Chem.. 276(3). 2108-2114 (2001)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] H.Tanimukai et al: "Regional distribution of presenilin-l messenger RNA in the embryonic rat brain : comparison with β-amyloid precursor protein messenger RNA localization"Neuroscience. 90 (1). 27-39 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Hitoshi Tanimukai et al: "Presenilin-2 mutation and polymorphism in Japanese Alzheimer disease patients"Clinica Chimica Acta. 283. 57-61 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Yuka Nakano et al: "Accumulation of murine amyloid β 42 in a gene-dosage-dependent manner in PS1 'knock-in' mice"Eur.J.Neurosci. 11. 2577-2581 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Katayama T et al: "Presenilin-1 mutations downregulate the signalling pathway of the unfolded-protein response"Nat Cell Biolog. 8. 479-485 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Takashi Kudo et al: "Are cerebrovascular factors involved in Alzheimer's disease ?"Neurobio.Aging.. 21. 215-224 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Naoya Sato et al: "Increased production of β-amyloid and vulnerability to endoplasmic reticulum stress by an aberrant spliced form of presenilin 2"J.Biol.Chem.. 276 (3). 2108-2114 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] 工藤喬 ら: "プレセニリン蛋白の病理"Pharma Medica. 18(2). 41-48 (2000)

    • Related Report
      2000 Annual Research Report
  • [Publications] 武田雅俊 ら: "Alzheimer型痴呆の最近の知見"精神科レビュー. 36. 11-19

    • Related Report
      2000 Annual Research Report
  • [Publications] 武田雅俊 ら: "抗痴呆薬開発の戦略-アミロイド蛋白とタウ蛋白の観点から"老年精神医誌. 11(2). 145-153

    • Related Report
      2000 Annual Research Report
  • [Publications] Takashi Kudo et al: "Are cerebrovascular factors involved in Alzheimer's disease?"Neurobio.Aging. 21. 215-224 (2000)

    • Related Report
      2000 Annual Research Report
  • [Publications] Ichiro Tsujio et al: "Inactivation of glycogen synthase kinase-3 by protein kinase C δ : Implications on regulation of τ phosphorylation"FEBS lett. 469(1). 111-117 (2000)

    • Related Report
      2000 Annual Research Report
  • [Publications] Naoya Sato et al: "Increased production of β-amyloid and vulnerability to endoplasmic reticulum stress by an aberrant spliced form of presenilin 2"J.Biol.Chem.. 276(3). 2108-2114

    • Related Report
      2000 Annual Research Report
  • [Publications] H.Tanimukai et al.: "Presenilin-2 mutation and polymorphism in Japanese Alzheimer disease patients"Clinica Chimica Acta. 283,. 57-61, (1999)

    • Related Report
      1999 Annual Research Report
  • [Publications] Y.Nakano et al.: "Accumulation of murine amvloid β42 in a gene-dosage-dependent manner in PS1 'knock-in'mice"Eur. J. Neurosci.. 11,. 2577-2581, (1999)

    • Related Report
      1999 Annual Research Report
  • [Publications] T.Katayama et al.: "Presenilin-1 mutations downregulate the signalling pathway of the unfolded-protein response"Nat Cell Biolog,. 8,. 479-485, (1999)

    • Related Report
      1999 Annual Research Report
  • [Publications] 工藤 喬ら: "アルツハイマー病の成因と一次予防"精神医学レビュー. 30、. 87-96、 (1999)

    • Related Report
      1999 Annual Research Report
  • [Publications] 工藤 喬ら: "プレセニリン蛋白の病理"Pharma Medica. 18(2). 41-48 (2000)

    • Related Report
      1999 Annual Research Report

URL: 

Published: 1999-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi